Licensed attorney since 2007. Licensed to practice law in Alabama, Mississippi, Georgia, and Washington D.C.
Concerned about a CTCL diagnosis after Dupixent? Proven injury lawyers for Alabama & Georgia.
Call now: 205-533-7878 (AL) | 706-550-9000 (GA) Free Consultation
If you or a loved one developed or were later diagnosed with cutaneous T-cell lymphoma (CTCL) after treatment with Dupixent (dupilumab), you deserve clear answers and fast help. Our team investigates potential drug-injury and misdiagnosis cases across Alabama and Georgia, coordinating with dermatology/oncology experts to review timelines, pathology, and whether earlier testing or warnings should have occurred.
Common Causes — And the Proof That Wins
| Cause | Key Evidence |
|---|---|
| CTCL mistaken for eczema before/while on Dupixent | Dermatology notes, photo timeline, biopsy/pathology slides, second-read by hematopathology expert |
| Delayed biopsy or inadequate workup of non-healing “eczema” | Care timelines, referral records, guideline comparisons, expert opinions |
| Failure to warn of lymphoma red-flags and need for monitoring | Medication guides, consent forms, pharmacy counseling logs, manufacturer literature |
| Inadequate follow-up after worsening or spreading lesions | Appointment intervals, triage messages, escalation requests, imaging/biopsy orders |
| Pharmacy or charting errors (missed alerts, documentation gaps) | EHR audit trails, pharmacy logs, adverse event reports, witness statements |
Why Choose Bodewell
| Advantage | Benefit |
|---|---|
| Drug-injury & misdiagnosis focus in AL/GA | We map timelines and guidelines to show what should have happened—and when |
| Pathology & oncology expert network | Independent slide reviews strengthen causation and liability theories |
| Proven results in complex injury claims | Strategic negotiation and trial readiness drive better settlements |
| Hands-on client service | Regular updates, direct access to your lawyer, and clear action plans |
| No fee unless we win | You pay nothing up front; we advance case costs |
Dupixent (dupilumab) and T-cell lymphoma (CTCL): what we look for
- Whether CTCL signs were present before Dupixent and went unrecognized
- Changes after starting Dupixent—worsening plaques, new tumors, lymph node symptoms
- Delays in biopsy, staging, or oncology referral
- Duty to warn, monitor, and promptly reassess non-responsive “eczema”
- Economic and human losses tied to the delay or failure to diagnose
Compensation May Include
- Medical bills (diagnostics, treatment, travel)
- Lost income and reduced earning capacity
- Pain, mental anguish, and loss of quality of life
- Caregiving and household help
- Wrongful death damages where applicable
Deadlines in Alabama & Georgia
Many claims must be filed within two years; some notices are shorter—call to confirm your exact deadline.
- Alabama: generally 2 years; contributory negligence may be raised by defendants; 6-month municipal notice can apply in certain claims.
- Georgia: generally 2 years; modified comparative fault; city/county ante-litem notice may apply for government entities.
What To Do Now
- Get your full medical file: dermatology, pathology slides/blocks, oncology, pharmacy records.
- Document your timeline: first symptoms, Dupixent start/stop dates, biopsies, referrals.
- List witnesses: family, pharmacists, nurses who observed symptom changes.
- Call us for a free review: we coordinate expert reads and deadline checks.
- Do not delay—evidence and deadlines are time-sensitive in AL/GA.
Talk to a lawyer today: 205-533-7878 (AL) | 706-550-9000 (GA) Free Consultation
Past results do not guarantee future outcomes. This page provides general information, not legal advice. For direct help, visit /contact/ or meet our team at /meet-our-team/.